We know more about Covid therapeutics than MSM, and even we (or at least I) will get surprised by some therapeutic development regarding a drug I knew nothing about prior to the news.
So I think they are more likely to wait for an EUA (or in our case, a conditional EUA would be even better) before they report.
Market Data 
Markets 
AI
